mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |